An RGD-restricted substrate interface is sufficient for the adhesion, growth and cartilage forming capacity of human chondrocytes
Chondrogenesis
DOI:
10.22203/ecm.v020a26
Publication Date:
2016-12-02T05:37:12Z
AUTHORS (9)
ABSTRACT
This study aimed at testing whether an RGD-restricted substrate interface is sufficient for adhesion and growth of human articular chondrocytes (HAC), it enhances their post expansion chondrogenic capacity. HAC/substrate interaction was restricted to RGD by modifying tissue culture polystyrene (TCPS) with a poly(ethylene glycol) (PEG) based copolymer system that renders the surface resistant protein adsorption while same time presenting bioactive RGD-containing peptide GCRGYGRGDSPG (RGD). As compared TCPS, HAC cultured on spread faster (1.9-fold), maintained higher type II collagen mRNA expression (4.9-fold) displayed 19% lower spreading area. On RGD, attachment efficiency (66±10%) proliferation rate (0.56±0.04 doublings/day), as well in subsequent differentiation phase, were similar those cells TCPS. In contrast, cartilaginous matrix deposition expanded slightly but consistently (15% glycosaminoglycan-to-DNA ratio). RDG (bioinactive peptide) PEG (no ligand) controls yielded drastically reduced (lower than 11%) 0.20 doublings/day). Collectively, these data indicate restriction through peptides support adhesion, maintenance cartilage forming The concept could thus be implemented materials repair, whereby situ recruited/infiltrated chondroprogenitor would proliferate maintaining ability differentiate generate tissue.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....